Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
61
result was found. Results that relate to
Safety
A clinical study of donepezil and buryphthalide in the treatment of Parkinson's syndrome
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1184-1191.
1965 times
422 times
SHE Canfang
ZHOU Meijun
ZHENG Miao
YU Huiyun
Parkinson's syndrome
Butylphthalein sequential therapy
Clinical efficacy
Safety
Details
Data-mining of piperacillin-tazobactam related adverse drug event signals based on FAERS
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1231-1239.
2247 times
498 times
LIU Jinwei
DONG Junli
SHAO Yu
ZHANG Shaohui
Piperacillin tazobactam
Adverse drug event
FAERS database
Signal mining
Diseases of blood and lymphatic system
Medication safety
Details
Antifibrinolytic drugs used in pediatric cardiac surgery: a systematic review and Meta-analysis
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1257-1264.
2186 times
423 times
WANG Qian
LIANG Xingchi
YANG Xinghai
LIU Jun
Cardiac surgery
Extracorporeal circulation
Antifibrinolytic drugs
Peptidase
Tranexamic acid
Aminocaproic acid
Cardiopulmonary
Hemostasis
Safety
Details
Ertugliflozin in the treatment of type 2 diabetes mellitus: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):778-789.
2402 times
485 times
QIN Fang
WU Kunrong
LIU Chengyu
LIU Daihua
Ertugliflozin
Type 2 diabetes mellitus
Efficacy
Safety
Cost-effectiveness
Rapid health technology assessment
Details
Romiplostim for the treatment of primary immune thrombocytopenia in adults: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(8):909-918.
3022 times
606 times
LI Jie
XIE Jun
HAN Yi
MENG Ying
GAO Liyuan
SHI Xiaohui
JIANG Zhitao
Romiplostim
Primary immune thrombocytopenia
Efficacy
Safety
Economic
Rapid health technology assessment
Details
Bibliometric analysis of active surveillance of post-marketing drug safety
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(9):1054-1063.
3144 times
503 times
WANG Conghui
YANG Ziming
WANG Zhenxing
SHI Wei
ALATENG Hua
XI Chengwei
PI Songning
YUAN Xinmin
ZHAN Siyan
Surveillance of post-marketing safety of drugs
Active surveillance
Pharmacovigilance
Bibliometrics
Visualization analysis
Details
Edaravone in the treatment of acute ischemic stroke: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1147-1155.
1687 times
302 times
YU Fang
ZENG Lu
WEI Anhua
GONG Xuepeng
WANG Lu
Edaravone
Acute ischemic stroke
Efficacy
Safety
Economy
Rapid health technology assessment
Details
Efgartigimod alfa in the treatment of generalized myasthenia gravis: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1156-1163.
1909 times
297 times
HUANG Gerile
LI Yujie
ZHANG Wenjing
GUO Hao
Efgartigimod alfa
Myasthenia gravis
Rapid health technology assessment
Efficaey
Safety
Economy
Details
Efficacy and safety of atogepant in prophylactic treatment of migraine: a Meta-analysis
Published on
New Medicine
2024,34(10):1151-1160.
1461 times
424 times
SHE Lang
CAI Junlong
TANG Lizhi
SHI Zhihua
CGRP receptor antagonists
Atogepant
Migraine
Meta-analysis
Efficacy
Safety
Details
Current status of cognition of laboratory biosafety education among medical students and its influencing factors
Published on
Journal of Mathematical Medicine
2024,37(12):953-960.
1807 times
165 times
CHEN Kehan
LUO Fan
LIU Yuanyuan
CHEN Shuliang
XIONG Hairong
HOU Wei
CHEN Liangjun
Laboratory biosafety
Medical students
Safety
education
Safety
training
Cognition
Details
Bibliometric analysis of studies on drug safety in the elderly with multiple diseases
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(12):1425-1435.
2672 times
228 times
LI Limin
WU Wenyu
WEI Fenfang
WU Jianru
The elderly
Multimorbidity
Drug safety
Bibliometrics
Visual analysis
Details
Safety of disialoganglioside targeted therapies in the treatment of pediatric neuroblastoma: a systematic review and Meta-analysis
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(2):191-204.
979 times
106 times
XING Ying
PANG Yu
ZHAN Siyan
Disialoganglioside
Neuroblastoma
Safety
Systematic review
Meta-analysis
Details
Research progress on the application and safety of botulinum toxin type A during pregnancy
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(2):216-223.
1023 times
131 times
LIU Yanan
CHENG Hong
Botulinum toxin type A
Safety
in pregnancy
Birth defects
Botulinum antitoxin
Details
Research progress on the analysis methods for phthalates plasticizers in pharmaceutical packaging materials and drugs
Published on
Frontiers in Pharmaceutical Sciences
2025,29(3):531-540.
283 times
64 times
JIA Feifei
HAN Xiaoxu
ZHAO Xia
Phthalates
Plasticizer
Drugs
Pharmaceutical packaging materials
Compatibility
Safety
Pretreatment
Analytical methods
Details
Efficacy and safety of Tislelizumab combined with chemotherapy in the treatment of non-small cell lung cancer: a Meta-analysis
Published on
New Medicine
2025,35(4):442-451.
131 times
64 times
WANG Kuan
TAN Xiao
GUO Yanni
Non-small cell lung cancer
Tislelizumab
Chemotherapy
Effectiveness
Safety
Meta-analysis
Details
上一页
1
2
3
4
5
下一页